NCCN Offers HER2 Testing for Breast Cancer Patients

Summary based on NCCN HER2 Testing Task Force Report JENKINTOWN, Pa., January 8, 2007 — The National Comprehensive Cancer Network (NCCN) and Research Advocacy Network have created an online report to educate breast cancer patients about the significance and importance of HER2 testing. Results of this test are essential in determining the correct treatment plan for breast cancer patients. Breast cancers can be categorized as HER2 positive or HER2 negative. HER2-positive breast cancer grows m...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news